Mangalam Drugs & Organics Complete Financial Statements

MANGALAM • Review detailed financials to uncover trends, confirm thesis & journal trades
3 Years of Data
2025 - 2023

Complete Financial Data Export

Export complete financial statements for Mangalam Drugs & Organics (MANGALAM). Downloads include all available records across all periods. For market performance, see the MANGALAM stock price today .

Profitability Ratios

Net Profit Margin -14.29% 2025 data
EBITDA Margin -6.12% 2025 data
Operating Margin -6.00% 2025 data
Return on Assets -1.91% 2025 data
Return on Equity -4.70% 2025 data

Balance Sheet Ratios

Current Ratio 7.65 2025 data
Debt to Equity 2.46 2025 data
Equity Ratio 40.71% 2025 data
Asset Turnover 0.13 2025 data

Year-over-Year Growth Analysis

Comparing Sept 2024 vs Sept 2025
Revenue Growth
-38.8%
Year-over-Year
Net Profit Growth
-333.3%
Year-over-Year
EBITDA Growth
-133.3%
Year-over-Year
Expense Growth
-26.8%
Year-over-Year
Assets Growth
+9.6%
Year-over-Year
Equity Growth
+9.6%
Year-over-Year
Liabilities Growth
+9.6%
Year-over-Year
Operating Cash Flow Growth
+975.0%
Year-over-Year
Investing Cash Flow Growth
-66.7%
Year-over-Year
Financing Cash Flow Growth
-540.0%
Year-over-Year

Income Statement

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Dec 2023
Revenue 49 73 57 80 102 77 89 97
Expenses 52 63 62 71 91 68 80 90
EBITDA -3 10 -5 9 12 8 9 7
Operating Profit Margin % -6.00% 14.00% -8.00% 11.00% 11.00% 11.00% 10.00% 7.00%
Depreciation 5 5 5 4 4 4 4 4
Interest 5 4 4 4 4 4 4 3
Profit Before Tax -13 2 -13 1 4 1 1 0
Tax -5 2 1 -2 0 -2 0 -1
Net Profit -7 0 -14 3 4 3 1 1
Earnings Per Share (₹) -4.64 0.04 -8.72 1.70 2.23 1.70 0.81 0.31

Balance Sheet

Years Annual Data ₹ Crores
Particulars 2025 2024
ASSETS
Total Assets 366 334
Current Assets 199 176
Fixed Assets 163 148
Capital Work in Progress 3 8
Investments 0 0
Other Assets 201 178
LIABILITIES
Total Liabilities 366 334
Current Liabilities 26 34
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 149 136
Share Capital 16 16
Reserves & Surplus 133 120

Cash Flow Statement

Periods ₹ Crores
Particulars March 2025 March 2024
Operating Activities 43 4
Investing Activities -20 -12
Financing Activities -22 5
Net Cash Flow 1 -3